Pischel R
Bezirksblutspendezentrale Neuruppin, DDR.
Folia Haematol Int Mag Klin Morphol Blutforsch. 1988;115(6):903-12.
In the course of their gravidity 161 women, among them 71 pregnant for the first time, 64 for the second time and 26 for the third time, were examined five times for the presence of cytotoxic HLA-A, B, C antibodies in NIH-LCT. This resulted in a total frequency of 23% of cytotoxic antibodies. Among those women pregnant for the first time there was an antibody rate of 18.3% (12.7% specifically), in those being in their second or third pregnancy the antibody rate amounted to 26%. In women with the second pregnancy the frequency of specific antibodies amounted to 17%, in those with the third pregnancy to 7.7%. HLA-antibodies were identified in the first gravida at the earliest between the 33rd and 40th week of pregnancy, in the second gravidas from the 12th to 16th or 33rd to 40th week of pregnancy and in the third gravidas from the 6th to 12th week. The results are discussed in comparison with HLA-mass screening of gravids carried out in the GDR in selected pregnant women and with other data taken from literature. They obtain a practical significance for performing a programme of HLA-antibody screening in a selected number of pregnant women with the aim of providing a possibility for gaining test sera from pregnant women for the purpose of improving the yield of test sera in comparison with the HLA-antibody screening test commonly used for pregnant women in the GDR.
在161名孕妇的孕期中,对她们进行了5次检测,以确定其在NIH-LCT中是否存在细胞毒性HLA-A、B、C抗体。其中71名孕妇为首次怀孕,64名孕妇为第二次怀孕,26名孕妇为第三次怀孕。细胞毒性抗体的总出现频率为23%。首次怀孕的女性中抗体率为18.3%(特异性抗体率为12.7%),第二次或第三次怀孕的女性中抗体率为26%。第二次怀孕的女性中特异性抗体频率为17%,第三次怀孕的女性中为7.7%。首次怀孕的孕妇最早在妊娠第33至40周检测出HLA抗体,第二次怀孕的孕妇在妊娠第12至16周或第33至40周检测出,第三次怀孕的孕妇在妊娠第6至12周检测出。将这些结果与民主德国对选定孕妇进行的孕妇HLA大规模筛查以及文献中的其他数据进行了比较讨论。这些结果对于在选定数量的孕妇中开展HLA抗体筛查计划具有实际意义,目的是为从孕妇中获取检测血清提供可能性,以便与民主德国常用的孕妇HLA抗体筛查试验相比提高检测血清的产量。